Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-01-500387
Filing Date
2001-12-21
Accepted
2001-12-21 00:00:00
Documents
9
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K PERIOD ENDED SEPTEMBER 30, 2001 a78011e10-k.htm 10-K 728539
3 EXHIBIT 3.2 a78011ex3-2.txt EX-3.2 2580
4 EXHIBIT 3.3 a78011ex3-3.txt EX-3.3 3968
5 EXHIBIT 3.4 a78011ex3-4.txt EX-3.4 71504
6 EXHIBIT 10.2 a78011ex10-2.txt EX-10.2 39089
7 EXHIBIT 10.4 a78011ex10-4.txt EX-10.4 39262
8 EXHIBIT 10.5 a78011ex10-5.txt EX-10.5 40606
9 EXHIBIT 21.1 a78011ex21-1.txt EX-21.1 407
10 EXHIBIT 23.1 a78011ex23-1.txt EX-23.1 701
  Complete submission text file 0000936392-01-500387.txt   929189
Mailing Address 9393 TOWN CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 200 SAN DIEGO CA 92121 8584102600
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 1821967
SIC: 2834 Pharmaceutical Preparations